Identification of a hidden outbreak due to the spread of a VIM-3-producing, extensive drug-resistant Pseudomonas aeruginosa (XDRPA) clone at a regional hospital in Taiwan

Epidemiology and Infection

Volumn 141, Issue 8, 2013, Pages 1713-1716

  Shu, J C ^a,b   Su, L H ^a,c   Chia, J H ^a,c   Huang, S H ^c   Kao, Y C ^c   Lee, S C ^c   Wu, T L ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Hidden outbreak; VIM 3; XDRPA

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLONE; EMERGENCY WARD; EPIDEMIC; EXTENSIVE DRUG RESISTANT PSEUDOMONAS AERUGINOSA; EXTENSIVE DRUG RESISTANT PSEUDOMONAS AERUGINOSA INFECTION; HEALTH CARE PERSONNEL; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL; HUMAN; INCIDENCE; INFECTION CONTROL; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; TAIWAN;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DISEASE OUTBREAKS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HOSPITALS, TEACHING; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; TAIWAN; TIME FACTORS;

EID: 84880336359     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881200204X     Document Type: Article

References (10)

1. FitzSimmons SC. The changing epidemiology of cystic fibrosis. Journal of Pediatrics 1993; 122: 1-9.
2. Yang MA, et al. Pseudomonas aeruginosa bacteremia in children over ten consecutive years: Analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes. Journal of Korean Medical Science 2011; 26: 612-618.
3. Shu JC, et al. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA). International Journal of Antimicrobial Agents 2012; 39: 217-222.
4. CLSI. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA, 2010.
5. Pfaller MA, Herwaldt LA. The clinical microbiology laboratory and infection control: Emerging pathogens, antimicrobial resistance, and new technology. Clinical Infectious Diseases 1997; 25: 858-870.
6. Garner JS, et al. CDC definitions for nosocomial infections, 1988. American Journal of Infection Control 1988; 16: 128-140.
7. Tsai MC, et al. Impact of an outbreak of severe acute respiratory syndrome on a hospital in Taiwan, ROC. Emergency Medicine Journal 2004; 21: 311-316.
8. Huang HH, et al. Declining emergency department visits and costs during the severe acute respiratory syndrome (SARS) outbreak. Journal of the Formosan Medical Association 2006; 105: 31-37.
9. Su LH, et al. Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens. Journal of Clinical Microbiology 2003; 41: 4726-4732.
10. Khandelwal C, Lathren C, Sloane P. Ten clinical situations in long-term care for which antibiotics are often prescribed but rarely necessary. Annals of Long-Term Care: Clinical Care and Aging 2012; 20: 23-29.